Application

PTO- 1478

Approved for use through 10/31/2024. OMB 0651-0009

U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number

---

PTO- 1478

Approved for use through 10/31/2024. OMB 0651-0009

U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number

Trademark/Service Mark Application, Principal Register

Serial Number: 97469150

Filing Date: 06/21/2022

To the Commissioner for Trademarks:

MARK: GRAHAM BRASWELL BIOTECHNOLOGIES (Standard Characters, see mark)
The literal element of the mark consists of GRAHAM BRASWELL BIOTECHNOLOGIES. The mark consists of standard characters, without claim to any particular font style, size, or color.
The applicant, Graham Braswell Biotechnologies Inc., a corporation of Delaware, having an address of
      150 Rivington Street, Apartment 3G
      New York, New York 10002
      United States
      XXXX

requests registration of the trademark/service mark identified above in the United States Patent and Trademark Office on the Principal Register established by the Act of July 5, 1946 (15 U.S.C. Section 1051 et seq.), as amended, for the following:

International Class 010:  Medical devices and apparatus, namely, catheter balloon inflation devices, drug coated balloon devices, dialysis catheters, covered stents, stent grafts, thrombectomy devices, thrombolysis devices, endovascular fistula creation devices, surgical fistula creation, or kidney transplant, to be used to treat end stage kidney disease via hemodialysis or peritoneal dialysis
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.

International Class 044:  Medical services, namely, providing in-clinic hemodialysis, at-home peritoneal dialysis, and at-home hemodialysis services related to chronic kidney disease and end-stage renal disease; medical and surgical center for the treatment of chronic kidney disease and end-stage renal disease
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.



The owner's/holder's proposed attorney information: Darren B. Cohen. Darren B. Cohen of Reed Smith LLP, is a member of the XX bar, admitted to the bar in XXXX, bar membership no. XXX, is located at
      599 Lexington Avenue
      New York, New York 10022
      United States
      212-549-0346(phone)
      dcohen@reedsmith.com
The docket/reference number is 400784.20002.
Darren B. Cohen submitted the following statement: The attorney of record is an active member in good standing of the bar of the highest court of a U.S. state, the District of Columbia, or any U.S. Commonwealth or territory.

The applicant's current Correspondence Information:

Darren B. Cohen

PRIMARY EMAIL FOR CORRESPONDENCE: dcohen@reedsmith.com        SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): nycipdocketing@reedsmith.com Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the applicant owner/holder and the applicant owner's/holder's attorney, if appointed, and that all official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS).

A fee payment in the amount of $700 has been submitted with the application, representing payment for 2 class(es).

Declaration

	Basis: If the applicant is filing the application based on use in commerce under 15 U.S.C. § 1051(a): The signatory believes that the applicant is the owner of the trademark/service mark sought to be registered; The mark is in use in commerce and was in use in commerce as of the filing date of the application on or in connection with the goods/services in the application; The specimen(s) shows the mark as used on or in connection with the goods/services in the application and was used on or in connection with the goods/services in the application as of the application filing date; and To the best of the signatory's knowledge and belief, the facts recited in the application are accurate. And/Or If the applicant is filing the application based on an intent to use the mark in commerce under 15 U.S.C. § 1051(b), § 1126(d), and/or § 1126(e): The signatory believes that the applicant is entitled to use the mark in commerce; The applicant has a bona fide intention to use the mark in commerce and had a bona fide intention to use the mark in commerce as of the application filing date on or in connection with the goods/services in the application; and To the best of the signatory's knowledge and belief, the facts recited in the application are accurate.
	To the best of the signatory's knowledge and belief, no other persons, except, if applicable, concurrent users, have the right to use the mark in commerce, either in the identical form or in such near resemblance as to be likely, when used on or in connection with the goods/services of such other persons, to cause confusion or mistake, or to deceive.
	To the best of the signatory's knowledge, information, and belief, formed after an inquiry reasonable under the circumstances, the allegations and other factual contentions made above have evidentiary support.
	The signatory being warned that willful false statements and the like are punishable by fine or imprisonment, or both, under 18 U.S.C. § 1001, and that such willful false statements and the like may jeopardize the validity of the application or submission or any registration resulting therefrom, declares that all statements made of his/her own knowledge are true and all statements made on information and belief are believed to be true.

Declaration Signature

Signature: /Darren B. Cohen/   Date: 06/21/2022
Signatory's Name: Darren B. Cohen
Signatory's Position: Attorney of Record, New York State Bar Member
Signatory's Phone Number: 212-549-0346
Signature method: Signed directly within the form
Payment Sale Number: 97469150
Payment Accounting Date: 06/21/2022

Serial Number: 97469150
Internet Transmission Date: Tue Jun 21 20:05:28 ET 2022
TEAS Stamp: USPTO/BAS-XXX.XXX.XXX.XX-202206212005283
76861-97469150-820f396e7311dc59676d4cd6b
d8cf692b9c43ebf5813a87dfbea3bc8cb04fc45f
9-CC-05271368-20220621195712445728